HCA Holdings (HCA) Misses Q3 EPS by 72c, Miss on Revenues; FY17 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
HCA Holdings (HCA) PT Lowered to $82 at Piper Jaffray Following 3Q
November 1, 2017 9:04 AM EDTPiper Jaffray lowered its price target on HCA Holdings (NYSE: HCA) to $82.00 (from $86.00) while maintaining a Overweight rating following the company's 3Q earnings report. HCA reported 3Q17 results in-line with the disappointing preannouncement driven by the strong hurricane season, weaker volumes and higher expense... More
HCA Holdings (HCA) PT Lowered to $79 at Morgan Stanley
November 1, 2017 8:55 AM EDTMorgan Stanley lowered its price target on HCA Holdings (NYSE: HCA) to $79.00 (from $85.00) while maintaining a Equalweight rating.
... MoreHCA Holdings (HCA) PT Lowered to $88 at Jefferies; Reiterates Buy
November 1, 2017 8:24 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $88.00 (from $90.00) while maintaining a Buy rating. Jefferies expects continued M&A activity that will enable management to achieve their LT EBITDA growth target of +4-6%. That said, analyst Brian Tanquilut believes HCA's... More
